Synopsis
The dopaminergic system
possesses striking plasticity compensating for motor aberrations from neuronal
loss. Little is known regarding the compensation mechanism during dopaminergic
loss, preventing the aberration from being arrested and treated early. Here we
present in vivo imaging evidence from
functional magnetic resonance imaging showing that, after dopaminergic
depletion, the dorsolateral striatum (DOLS) exhibited an early and transient
vasodilation cluster in response to specific forepaw stimulation. Activation of
DOLS NMDA receptors causes this vasodilation, protects dopaminergic fibers from
denervation, and counteracts motor deficits. The findings have clinical
implications for early detection and intervention in brain disorders such as
Parkinson’s disease.Purpose
Upon dopaminergic
depletion, both patients with Parkinson’s disease (PD) and experimental animals
show behavioral manifestations only with substantial neuronal loss (80~90%)1, 2. Identification and visualization of the adaptive
plasticity for dopaminergic injuries remains lacking in the neuroscience
literature, with both its location and neurochemical nature being most debated1, 3-10.
Functional magnetic resonance imaging (fMRI) can be a useful tool to pinpoint
the location and neurochemistry of changes in brain activity11. In this study, a pain-evoked cerebral blood volume
(CBV)-weighted fMRI paradigm is used to investigate the crosstalk between the
divergent glutamatergic and dopaminergic systems that converge on the striatum,
to determine what currently remains unknown regarding the compensatory
plasticity upon dopaminergic depletion.
Methods
The rat PD animal model was induced by an
intraperitoneal injection of desipramine (15 mg/kg) and then lesioning the
right substantia nigra (SN) with 15 mg of 6-hydroxydopamine (6-OHDA) in a volume
of 3 ml dissolved in ice-cold 0.02% ascorbic acid. The
coordinates for the right SN pars compacta were 5.3 mm posterior,
2.1 mm lateral, and 8.2 mm ventral from the bregma. For measuring the
motor deficits, the rats were injected intraperitoneally with methamphetamine
(2 mg/kg), and then their rotation behavior was recorded and analyzed. A
rat is considered to be parkinsonian when the rotation reaches 360 turns/h.
For the day 1 group, the rats received either saline or MK801 via the tail vein
at 15 minutes before the administration of methamphetamine.
fMRI was conducted using a 4.7-T spectrometer (Biospec
47/40, Bruker, Germany) with a 72-mm-volume coil as the radiofrequency
transmitter and a quadrature surface coil as the receiver. For each sensory
stimulation evoked fMRI data set, a time series of 60 images were acquired in
the axial plane. The first 12, second 12, third 12, fourth 12, and last 12 time
frames correspond to the off, on, off, on, and off phases of nociceptive
electrical stimulation, respectively, which was delivered to a left or right
forepaw via a pair of needle electrodes. Gradient-echo images were acquired in
the time series with a repetition time of 150 ms, an echo time of
15 ms, a flip angle of 22.5°, a field of view of 2.56 cm by 2.56 cm, a
slice thickness of 1.5 mm, an acquisition matrix of 128×64 (zero-filled to
128×128), and a temporal resolution of 9.6 s. The stimulation intensity
was 3 mA or 1 mA, administered by a constant-current stimulator (model
2100, A-M Systems, Carlsborg, WA, USA). The contrast agent was from MegaPro
Biomedical Co. Ltd. fMRI correlation maps were generated by the Pearson
correlation coefficient (CC) between the image signals and the
off–on–off–on–off electrical stimulation paradigm on a voxel-by-voxel basis
using the cross-correlation method 12. The cutoff point for the CC was r=±0.2513, 14. NMDAR and D1R antagonism were achieved by
MK801 and SKF83566, respectively, injected intravenously during MRI 15
16. The designated administration
time point was 5 minutes before the acquisition of a stimulation-evoked fMRI
dataset (an off-on-off-on-off stimulation paradigm). After
fMRI experiments, the rats were perfused for immunohistology using 4%
paraformaldehyde, and the brains were cryosectioned at 50 mm and stained for tyrosine hydroxylase (TH).
Results
When the painful
stimulation was applied to the left
forepaw of the rats in the early stage after right intranigral 6-OHDA (15µg/Kg) injection, a remarkable novel
vasodilation cluster was observed in the DOLS ipsilateral to the lesioned SN at
day 1 post-lesion. The DOLS vasodilation is a major sign that marks the
difference between the early and late stages of dopamine depletion. The DOLS
vasodilation occurs in response to both high intensity (noxious) and low
intensity (innoxious) electrical stimulation. Pharmacological testing indicates
that the evoked DOLS vasodilation is caused primarily by NMDAR, and secondarily
by D1R. When examining the dopaminergic fibers of these brain tissues, we found
that the location of the residual dopaminergic fibers coincides with the region
exhibiting vasodilation. Moreover, behavioral testing shows that NMDAR
antagonism advanced the motor dysfunction of the day 1 rats to a level
considered parkinsonism, suggesting that DOLSN activity produces effects compensating
for the motor dysfunction in the early stage after dopaminergic depletion.
Conclusions
For the first time, robust
evidence is available that indicates an important mechanism to motor
compensation upon dopaminergic loss being DOLSN-dependent mediation. In this,
the sensory stimulus-evoked CBV-weighted fMRI technique plays an indispensable
role in detecting the mechanism. fMRI reveals that DOLSN activity represents
the crosstalk between the glutamatergic corticostriatal tracts and dopaminergic
nigrostriatal fibers at the convergent synaptic site to cope with the
endangered dopaminergic system.
Acknowledgements
No acknowledgement found.References
1. Zigmond MJ, Abercrombie ED, Berger
TW, Grace AA, Stricker EM. Compensations after lesions of central dopaminergic
neurons: Some clinical and basic implications. Trends in neurosciences. 1990;13:290-296
2. Lloyd KG. Cns compensation to
dopamine neuron loss in parkinson's disease. Advances in experimental medicine and biology. 1977;90:255-266
3. Arkadir D, Bergman H, Fahn S.
Redundant dopaminergic activity may enable compensatory axonal sprouting in
parkinson disease. Neurology.
2014;82:1093-1098
4. Bezard E, Gross CE, Brotchie JM.
Presymptomatic compensation in parkinson's disease is not dopamine-mediated. Trends in neurosciences. 2003;26:215-221
5. Brotchie J, Fitzer-Attas C.
Mechanisms compensating for dopamine loss in early parkinson disease. Neurology. 2009;72:S32-38
6. Dreyer JK. Three mechanisms by
which striatal denervation causes breakdown of dopamine signaling. J Neurosci. 2014;34:12444-12456
7. Kim SR, Chen X, Oo TF, Kareva T,
Yarygina O, Wang C, During M, Kholodilov N, Burke RE. Dopaminergic pathway
reconstruction by akt/rheb-induced axon regeneration. Ann Neurol. 2011;70:110-120
8. Lee CS, Samii A, Sossi V, Ruth TJ,
Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente-Fernandez R, Calne DB,
Stoessl AJ. In vivo positron emission tomographic evidence for compensatory
changes in presynaptic dopaminergic nerve terminals in parkinson's disease. Ann Neurol. 2000;47:493-503
9. Meurers BH, Dziewczapolski G, Shi
T, Bittner A, Kamme F, Shults CW. Dopamine depletion induces distinct
compensatory gene expression changes in darpp-32 signal transduction cascades
of striatonigral and striatopallidal neurons. J Neurosci. 2009;29:6828-6839
10. Robinson TE, Mocsary Z, Camp DM,
Whishaw IQ. Time course of recovery of extracellular dopamine following partial
damage to the nigrostriatal dopamine system. J Neurosci. 1994;14:2687-2696
11. Logothetis NK, Pauls J, Augath M,
Trinath T, Oeltermann A. Neurophysiological investigation of the basis of the
fmri signal. Nature. 2001;412:150-157
12. Bandettini PA, Jesmanowicz A, Wong
EC, Hyde JS. Processing strategies for time-course data sets in functional mri
of the human brain. Magn Reson Med.
1993;30:161-173
13. Chen CCV, Shih YYI, Chang C.
Dopaminergic imaging of nonmotor manifestations in a rat model of parkinson's
disease by fmri. Neurobiol Dis.
2013;49:99-106
14. Shih YYI, Chen CCV, Shyu BC, Lin ZJ,
Chiang YC, Jaw FS, Chen YY, Chang C. A new scenario for negative functional
magnetic resonance imaging signals: Endogenous neurotransmission. J Neurosci. 2009;29:3036-3044
15. Gsell W, Burke M, Wiedermann D,
Bonvento G, Silva AC, Dauphin F, Buhrle C, Hoehn M, Schwindt W. Differential
effects of nmda and ampa glutamate receptors on functional magnetic resonance
imaging signals and evoked neuronal activity during forepaw stimulation of the
rat. J Neurosci. 2006;26:8409-8416
16. McLaughlin PJ, Winston KM, Swezey LA,
Vemuri VK, Makriyannis A, Salamone JD. Detailed analysis of food-reinforced
operant lever pressing distinguishes effects of a cannabinoid cb1 inverse
agonist and dopamine d1 and d2 antagonists. Pharmacology,
biochemistry, and behavior. 2010;96:75-81